Preclinical Development of a Vaccine ‘Against Smoking’

Publisher： Karger

E-ISSN： 2296-5262|25|5|406-411

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.25, Iss.5, 2002-11, pp. : 406-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Live Recombinant Vaccine Candidates Against Tuberculosis

By Hess Jürgen   Kaufmann Stefan H. E.  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 12, 2001-12 ,pp. : 77-78

Informa Healthcare

Access to resources Recommend Favorite

Development of Live Recombinant Vaccine Candidates Against Tuberculosis

By Hess Jürgen   Kaufmann Stefan H. E.  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 10, 2001-10 ,pp. : 723-724

Informa Healthcare

Access to resources Recommend Favorite

Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus

By Tan Ming   Jiang Xi  

Nanomedicine, Vol. 7, Iss. 6, 2012-06 ,pp. : 889-897

Future Medicine

Access to resources Recommend Favorite

Discovery and preclinical development of new antibiotics

By Hughes Diarmaid   Karlén Anders  

Upsala Journal of Medical Sciences, Vol. 119, Iss. 2, 2014-05 ,pp. : 162-169

Informa Healthcare

Access to resources Recommend Favorite

The Impact of Preclinical Irreproducibility on Drug Development

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 1, 2015-01 ,pp. : 16-18

John Wiley & Sons Inc

Access to resources Recommend Favorite